We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

152 hedge funds and large institutions have $2.47B invested in IVERIC bio, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 47 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more call options, than puts

Call options by funds: $15.2M | Put options by funds: $5.77M

91% more capital invested

Capital invested by funds: $1.29B → $2.47B (+$1.18B)

31% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 26

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

11% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 47

6% more funds holding

Funds holding: 144152 (+8)

Holders
152
Holders Change
+8
Holders Change %
+5.56%
% of All Funds
3.99%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
34
Increased
52
Reduced
47
Closed
26
Calls
$15.2M
Puts
$5.77M
Net Calls
+$9.39M
Net Calls Change
+$11.5M
Name Holding Trade Value Shares
Change
Change in
Stake
PI
51
Putnam Investments
Massachusetts
$3.32M -$44.2K -765 -2%
EI
52
EAM Investors
California
$3.3M +$2.43M +41,999 New
UBS Group
53
UBS Group
Switzerland
$3.29M +$2.13M +36,856 +732%
AllianceBernstein
54
AllianceBernstein
Tennessee
$3.28M -$8.1K -140 -0.3%
TD Asset Management
55
TD Asset Management
Ontario, Canada
$3.18M -$46.3K -800 -2%
NFA
56
Nationwide Fund Advisors
Ohio
$2.83M +$4.51K +78 +0.2%
BBA
57
Baker Bros. Advisors
New York
$2.8M
TA
58
Teachers Advisors
New York
$2.75M +$33.7K +582 +2%
Citadel Advisors
59
Citadel Advisors
Florida
$2.69M +$1.48M +25,560 +296%
TAM
60
Tocqueville Asset Management
New York
$2.66M +$57.8K +1,000 +3%
Deutsche Bank
61
Deutsche Bank
Germany
$2.63M +$422K +7,306 +28%
ProShare Advisors
62
ProShare Advisors
Maryland
$2.48M +$162K +2,802 +10%
Mackenzie Financial
63
Mackenzie Financial
Ontario, Canada
$2.47M -$1.05M -18,200 -37%
Swiss National Bank
64
Swiss National Bank
Switzerland
$2.41M
BA
65
BlackRock Advisors
Delaware
$2.22M +$404K +6,984 +33%
PAMU
66
Pictet Asset Management (UK)
United Kingdom
$2.21M -$1.93M -33,400 -54%
Ameriprise
67
Ameriprise
Minnesota
$2.18M +$1.61M +27,763 New
Jacobs Levy Equity Management
68
Jacobs Levy Equity Management
New Jersey
$2.13M -$605K -10,460 -28%
First Trust Advisors
69
First Trust Advisors
Illinois
$1.98M +$1.46M +25,262 New
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$1.92M +$178K +3,080 +14%
DBG
71
De Burlo Group
Massachusetts
$1.7M +$1.25M +21,700 New
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$1.5M -$268K -4,630 -20%
GF
73
Gabelli Funds
New York
$1.49M
HighTower Advisors
74
HighTower Advisors
Illinois
$1.42M +$508K +8,788 +94%
UBS AM
75
UBS AM
Illinois
$1.42M +$296K +5,112 +40%

ISEE Hedge Fund Activity: Q4 2015 in Review

152 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2015, worth a combined $2.47B — up 91% from $1.29B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ISEE positions and 26 closed out — a net gain of 8 holders — while 52 added to existing stakes and 47 trimmed.

The largest buyer was Millennium Management, adding an estimated $60.6M. The largest seller was Morgan Stanley, cutting an estimated $59.6M.

  • 152 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2015, up from 144 in Q3 2015.
  • Funds reported $2.47B of IVERIC bio, Inc. Common Stock stock for Q4 2015, up 91% quarter-over-quarter.
  • 34 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2015 and 26 closed out, a net change of +8 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2015 was Millennium Management, an estimated $60.6M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2015 was Morgan Stanley, an estimated $59.6M sold.

Based on aggregated 13F filings for Q4 2015.